143 related articles for article (PubMed ID: 36149480)
21. New onset of axial spondyloarthropathy in patients treated with isotretinoin for acne vulgaris: incidence, follow-up, and MRI findings.
Elnady B; Elkhouly T; Dawoud NM; Desouky DE; Kewan HH; Dawoud DM; Ritchlin C
Clin Rheumatol; 2020 Jun; 39(6):1829-1838. PubMed ID: 32034553
[TBL] [Abstract][Full Text] [Related]
22. High-dose isotretinoin in acne vulgaris: improved treatment outcomes and quality of life.
Cyrulnik AA; Viola KV; Gewirtzman AJ; Cohen SR
Int J Dermatol; 2012 Sep; 51(9):1123-30. PubMed ID: 22909370
[TBL] [Abstract][Full Text] [Related]
23. [Acne flare-up and deterioration with oral isotretinoin].
Chivot M
Ann Dermatol Venereol; 2001 Mar; 128(3 Pt 1):224-8. PubMed ID: 11319385
[TBL] [Abstract][Full Text] [Related]
24. The frequency of hematuria in acne vulgaris patients during isotretinoin treatment.
Yesilkaya B; Alli N; Artuz RF; Ulu E; Kartal D; Cinar SL
Cutan Ocul Toxicol; 2017 Mar; 36(1):74-76. PubMed ID: 26938860
[TBL] [Abstract][Full Text] [Related]
25. Association of suicide attempts with acne and treatment with isotretinoin: retrospective Swedish cohort study.
Sundström A; Alfredsson L; Sjölin-Forsberg G; Gerdén B; Bergman U; Jokinen J
BMJ; 2010 Nov; 341():c5812. PubMed ID: 21071484
[TBL] [Abstract][Full Text] [Related]
26. Circumventing iPLEDGE: Circumventing ethical responsibility?
Lee KC; Bercovitch L
J Am Acad Dermatol; 2017 Dec; 77(6):1185-1187. PubMed ID: 29132856
[No Abstract] [Full Text] [Related]
27. Evaluation of the changes in sebum, moisturization and elasticity in acne vulgaris patients receiving systemic isotretinoin treatment.
Gencebay G; Aşkın Ö; Serdaroğlu S
Cutan Ocul Toxicol; 2021 Jun; 40(2):140-144. PubMed ID: 33978534
[TBL] [Abstract][Full Text] [Related]
28. Isotretinoin and the risk of depression in patients with acne vulgaris: a case-crossover study.
Azoulay L; Blais L; Koren G; LeLorier J; Bérard A
J Clin Psychiatry; 2008 Apr; 69(4):526-32. PubMed ID: 18363422
[TBL] [Abstract][Full Text] [Related]
29. Isotretinoin systemic therapy and the shadow cast upon dermatology's downtrodden hero.
Lowenstein EB; Lowenstein EJ
Clin Dermatol; 2011; 29(6):652-61. PubMed ID: 22014987
[TBL] [Abstract][Full Text] [Related]
30. Comparison of the efficacies of intermittent and continuous low-dose isotretinoin regimens in the treatment of moderate acne vulgaris.
Boyraz N; Mustak PK
Int J Dermatol; 2013 Oct; 52(10):1265-7. PubMed ID: 23675954
[TBL] [Abstract][Full Text] [Related]
31. No association found between patients receiving isotretinoin for acne and the development of depression in a Canadian prospective cohort.
Cohen J; Adams S; Patten S
Can J Clin Pharmacol; 2007; 14(2):e227-33. PubMed ID: 17556790
[TBL] [Abstract][Full Text] [Related]
32. Isotretinoin for acne and rosacea.
Watson KD; Miest RY; Tollefson MM
Semin Cutan Med Surg; 2016 Jun; 35(2):79-86. PubMed ID: 27416313
[TBL] [Abstract][Full Text] [Related]
33. Association of Race/Ethnicity and Sex With Differences in Health Care Use and Treatment for Acne.
Barbieri JS; Shin DB; Wang S; Margolis DJ; Takeshita J
JAMA Dermatol; 2020 Mar; 156(3):312-319. PubMed ID: 32022834
[TBL] [Abstract][Full Text] [Related]
34. Managing nonteratogenic adverse reactions to isotretinoin treatment for acne vulgaris.
Reilly BK; Ritsema TS
JAAPA; 2015 Jul; 28(7):34-9. PubMed ID: 26107793
[TBL] [Abstract][Full Text] [Related]
35. Sacroiliitis after use of oral isotretinoin--association with acne fulminans or adverse effect?
Geller AS; Alagia RF
An Bras Dermatol; 2013; 88(6 Suppl 1):193-6. PubMed ID: 24346917
[TBL] [Abstract][Full Text] [Related]
36. [Isotretinoin and depressive symptoms in patiens with severe and recurrent acne].
Rubio-García L; Pulido-Díaz N; Jímenez-López JL
Rev Med Inst Mex Seguro Soc; 2015; 53 Suppl 1():S54-9. PubMed ID: 26020665
[TBL] [Abstract][Full Text] [Related]
37. Contraceptive counseling for iPLEDGE and its burden on dermatologists.
Owens KE; Jiang SW; Nicholas MW
Arch Dermatol Res; 2024 May; 316(6):287. PubMed ID: 38805059
[TBL] [Abstract][Full Text] [Related]
38. Isotretinoin: controversies, facts, and recommendations.
Bauer LB; Ornelas JN; Elston DM; Alikhan A
Expert Rev Clin Pharmacol; 2016 Nov; 9(11):1435-1442. PubMed ID: 27414637
[TBL] [Abstract][Full Text] [Related]
39. Laboratory Monitoring During Isotretinoin Therapy for Acne: A Systematic Review and Meta-analysis.
Lee YH; Scharnitz TP; Muscat J; Chen A; Gupta-Elera G; Kirby JS
JAMA Dermatol; 2016 Jan; 152(1):35-44. PubMed ID: 26630323
[TBL] [Abstract][Full Text] [Related]
40. Analysis of clinical efficacy, side effects, and laboratory changes among patients with acne vulgaris receiving single versus twice daily dose of oral isotretinoin.
Ahmad HM
Dermatol Ther; 2015; 28(3):151-7. PubMed ID: 25754162
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
